Free Trial
NASDAQ:PROF

Profound Medical (PROF) Stock Price, News & Analysis

Profound Medical logo
$7.35
+0.08 (+1.10%)
(As of 11/1/2024 ET)

About Profound Medical Stock (NASDAQ:PROF)

Key Stats

Today's Range
$7.25
$7.43
50-Day Range
$7.21
$9.34
52-Week Range
$7.11
$11.69
Volume
9,743 shs
Average Volume
29,291 shs
Market Capitalization
$181.25 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$13.75
Consensus Rating
Buy

Company Overview

Profound Medical Corp., together with its subsidiaries, operates as a commercial-stage medical device company that develops and markets incision-free therapeutic systems for the image guided ablation of diseased tissue in Canada, Germany, the United States, and Finland. Its lead product TULSA-PRO system combines magnetic resonance imaging(MRI), robotically-driven transurethral sweeping action/thermal ultrasound and closed-loop temperature feedback control to provide precise, flexible, and durable ablation of a surgeon defined region of prostate and protect the urethra and rectum. The company also offers Sonalleve, which combines real-time MRI and thermometry for the treatment of uterine fibroids, adenomyotic tissue, palliative pain treatment of bone metastases, osteoid osteoma, and management of benign tumors. Profound Medical Corp. is headquartered in Mississauga, Canada.

Profound Medical Stock Analysis - MarketRank™

See Top Rated MarketRank™ Stocks
43rd Percentile Overall Score

PROF MarketRank™: 

Profound Medical scored higher than 43% of companies evaluated by MarketBeat, and ranked 679th out of 975 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Profound Medical has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 3 buy ratings, no hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    Profound Medical has received no research coverage in the past 90 days.

  • Read more about Profound Medical's stock forecast and price target.
  • Earnings Growth

    Earnings for Profound Medical are expected to grow in the coming year, from ($1.19) to ($0.84) per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Profound Medical is -6.02, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Profound Medical is -6.02, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    Profound Medical has a P/B Ratio of 5.74. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

  • Read more about Profound Medical's valuation and earnings.
  • Percentage of Shares Shorted

    1.36% of the outstanding shares of Profound Medical have been sold short.
  • Short Interest Ratio / Days to Cover

    Profound Medical has a short interest ratio ("days to cover") of 7.1.
  • Change versus previous month

    Short interest in Profound Medical has recently decreased by 1.53%, indicating that investor sentiment is improving.
  • Dividend Yield

    Profound Medical does not currently pay a dividend.

  • Dividend Growth

    Profound Medical does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    1.36% of the outstanding shares of Profound Medical have been sold short.
  • Short Interest Ratio / Days to Cover

    Profound Medical has a short interest ratio ("days to cover") of 7.1.
  • Change versus previous month

    Short interest in Profound Medical has recently decreased by 1.53%, indicating that investor sentiment is improving.
  • News Coverage This Week

    MarketBeat has tracked 2 news articles for Profound Medical this week, compared to 3 articles on an average week.
  • Search Interest

    1 people have searched for PROF on MarketBeat in the last 30 days.
  • MarketBeat Follows

    1 people have added Profound Medical to their MarketBeat watchlist in the last 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Profound Medical insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    Only 1.52% of the stock of Profound Medical is held by insiders.

  • Percentage Held by Institutions

    47.86% of the stock of Profound Medical is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about Profound Medical's insider trading history.
Receive PROF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Profound Medical and its competitors with MarketBeat's FREE daily newsletter.

PROF Stock News Headlines

Profound Medical (PROF) to Release Quarterly Earnings on Thursday
Sell NVDA Now?
Guess who's selling NVDA next The most successful hedge fund in history quietly sold 500,000 shares. Here's what that means for your money. Billionaire Wall Street investors are quietly offloading millions of shares. What do they know that you don't? It's arguably the most popular stock in the world. Now, one 50-year Wall Street legend says its day in the sun could finally be coming to an end. Last year, he warned of two stocks that went on to crash 60%.
See More Headlines

PROF Stock Analysis - Frequently Asked Questions

Profound Medical's stock was trading at $8.49 at the beginning of 2024. Since then, PROF shares have decreased by 13.4% and is now trading at $7.35.
View the best growth stocks for 2024 here
.

Profound Medical Corp. (NASDAQ:PROF) posted its quarterly earnings data on Thursday, August, 8th. The company reported ($0.28) EPS for the quarter, hitting the consensus estimate of ($0.28). The business earned $2.23 million during the quarter, compared to analysts' expectations of $2.50 million. Profound Medical had a negative trailing twelve-month return on equity of 71.28% and a negative net margin of 350.14%.

Top institutional shareholders of Profound Medical include Rosalind Advisors Inc. (1.97%).

Shares of PROF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

Based on aggregate information from My MarketBeat watchlists, some other companies that Profound Medical investors own include Block (SQ), Alibaba Group (BABA), Pfizer (PFE), NVIDIA (NVDA), PayPal (PYPL), Tesla (TSLA) and DocuSign (DOCU).

Company Calendar

Last Earnings
8/08/2024
Today
11/02/2024
Next Earnings (Confirmed)
11/07/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Surgical & medical instruments
Sub-Industry
Medical Equipment
Current Symbol
NASDAQ:PROF
Employees
150
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$13.75
High Stock Price Target
$16.50
Low Stock Price Target
$12.00
Potential Upside/Downside
+87.1%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
3 Analysts

Profitability

Net Income
$-28,570,000.00
Net Margins
-350.14%
Pretax Margin
-352.07%

Debt

Sales & Book Value

Annual Sales
$7.20 million
Book Value
$1.28 per share

Miscellaneous

Free Float
24,287,000
Market Cap
$181.25 million
Optionable
Optionable
Beta
0.82
10 Best Stocks to Own in 2025 Cover

Click the link below and we'll send you MarketBeat's list of the 10 best stocks to own in 2025 and why they should be in your portfolio.

Get This Free Report

This page (NASDAQ:PROF) was last updated on 11/2/2024 by MarketBeat.com Staff
From Our Partners